Shersher David D, Liptay Michael J
Thoracic Oncology Program, Rush University Medical Center, Chicago, IL 60612, USA.
Surg Oncol Clin N Am. 2013 Apr;22(2):345-55. doi: 10.1016/j.soc.2012.12.004. Epub 2012 Dec 29.
Although the treatment of malignant pleural mesothelioma has been refined during the past two decades, overall survival from this rather uncommon disease is still extremely poor. Here we review the current multimodal diagnostic and treatment options for patients with mesothelioma and discuss promising new experimental concepts in this disease.
尽管在过去二十年中恶性胸膜间皮瘤的治疗已得到改进，但这种相当罕见疾病的总体生存率仍然极低。在此，我们回顾了目前针对间皮瘤患者的多模式诊断和治疗选择，并讨论了该疾病中前景广阔的新实验概念。
